ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2338

“It Was like No One Is Listening to Me”�: A Qualitative Study of the Lived Experiences of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance in Assessments of Disease Activity

John M. Davis III1, Zoran Kvrgic2, Melissa M. Plagge1, Jennifer L. Ridgeway3 and Gladys B. Asiedu3, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Rheumatology, Mayo Clinic, Rochester, MN, 3Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Communication, qualitative and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Discordance between patients with rheumatoid arthritis (RA) and their rheumatologists in their global assessments of disease activity affects around 33% of clinical encounters. The objective of this study was to understand the perspective of patients with measured discordance on issues like disease assessments and patient-provider communication.

Methods: We conducted individual interviews with 20 patients (six males and 20 females) with RA (ACR/EULAR 2010 criteria) who had patient-physician discordance as defined by a ≥25-mm absolute difference in global assessments of disease activity at the most recent rheumatology appointment within 4 weeks (median patient global assessment = 56 mm; median provider global assessment =15 mm). The interviews were audio recorded, transcribed verbatim, and checked for accuracy. Interviews were analyzed using content analysis by coding the texts, identifying themes and patterns and then grouping them into meaningful clusters. To aid interpretation of the qualitative data, the Clinical Disease Activity Index (CDAI) was collected from the most recent clinical evaluation, and participants also completed the pain visual analog scale (VAS) and the Patient Health Questionnaire-9 (PHQ-9).

Results: The average age was 63 years (range 38-85). The medians (IQRs) for CDAI, pain VAS, and PHQ-9 were 10.2 (8.3 to 22.4), 61.5 (42.8 to 77.8), and 3.5 (2 to 7.8), respectively. Qualitative data analysis yielded six key themes (Table). Many patients described being misunderstood by others, including medical and non-medical communities, and distinguished their experiences from those with other, perhaps more objectively defined diseases. Not all patients reported feeling like their providers assessments differed from their own, but those who perceived discordance attributed it to providers’ failure to listen, lack of empathy, or rushed behaviors. Many reported consternation with completing pain, disability and global activity ratings, and few reported discussions of these with providers. Other patients did not necessarily understand the meaning of disease assessments (e.g., blood tests, x-rays). Patients also described the psychosocial burden of RA on daily life, noting unmet psychosocial needs and confusion about whether these issues should be addressed with their providers.

Conclusion: The findings of this study reveal several key themes for rheumatologists to take into account in their daily approach to patients with RA. The results should inform future studies aiming to enhance patient-physician communication and to develop management approaches targeting optimal health outcomes for patients with RA, including those that acknowledge the impact that RA has on daily living, which may not be currently perceived as important to disease assessments in clinic.

 


Disclosure: J. M. Davis III, None; Z. Kvrgic, None; M. M. Plagge, None; J. L. Ridgeway, None; G. B. Asiedu, None.

To cite this abstract in AMA style:

Davis JM III, Kvrgic Z, Plagge MM, Ridgeway JL, Asiedu GB. “It Was like No One Is Listening to Me”�: A Qualitative Study of the Lived Experiences of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance in Assessments of Disease Activity [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/it-was-like-no-one-is-listening-to-me%ef%bf%bd-a-qualitative-study-of-the-lived-experiences-of-patients-with-rheumatoid-arthritis-in-the-setting-of-patient-physician-discordance-in-assessments-of-d/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/it-was-like-no-one-is-listening-to-me%ef%bf%bd-a-qualitative-study-of-the-lived-experiences-of-patients-with-rheumatoid-arthritis-in-the-setting-of-patient-physician-discordance-in-assessments-of-d/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology